XML 28 R112.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Condensed Consolidating Financials - Schedule of Supplemental Condensed Consolidating Statement of Operations (Detail) (USD $)
 3 Months Ended 12 Months Ended
Sep. 27, 2014
Jun. 28, 2014
Mar. 29, 2014
Dec. 28, 2013
Sep. 28, 2013
Jun. 29, 2013
Mar. 30, 2013
Mar. 30, 2013
Dec. 29, 2012
Sep. 29, 2012
Sep. 27, 2014
Sep. 28, 2013
Sep. 29, 2012
Revenues:                          
Product                     $ 2,094,900,000 $ 2,100,900,000 $ 1,657,700,000
Service and other                     435,800,000 391,400,000 344,900,000
Revenues 660,600,000 632,600,000 625,000,000 612,400,000 622,100,000 626,100,000   612,700,000 631,400,000   2,530,700,000 2,492,300,000 2,002,600,000
Costs of revenues:                          
Product                     731,300,000 818,200,000 616,800,000
Amortization of intangible assets                     314,600,000 307,900,000 201,900,000
Impairment of intangible assets                     26,600,000 1,700,000 0
Service and other                     212,700,000 203,100,000 189,500,000
Gross Profit 345,000,000 312,800,000 282,100,000 305,600,000 290,600,000 309,800,000   279,300,000 281,700,000   1,245,500,000 1,161,400,000 994,400,000
Operating expenses:                          
Research and development                     203,200,000 197,600,000 131,000,000
Selling and marketing                     331,700,000 342,100,000 322,300,000
General and administrative                     259,800,000 227,700,000 220,500,000
Amortization of intangible assets                     113,800,000 112,600,000 72,000,000
Impairment of intangible assets                     5,600,000 0 0
Contingent consideration – compensation expense                     0 80,000,000 81,000,000
Contingent consideration – fair value adjustments                     0 11,300,000 38,500,000
Impairment of goodwill         1,100,000,000         5,800,000 0 1,117,400,000 5,800,000
Gain on sale of intellectual property                 (53,900,000)   0 (53,900,000) (12,400,000)
Acquired in-process research and development                     0 0 4,500,000
Restructuring and divestiture charges 15,100,000 6,700,000 11,600,000 18,400,000 9,700,000 6,700,000   12,500,000     51,700,000 32,800,000 17,500,000
Operating expenses                     965,800,000 2,067,600,000 880,700,000
Income (loss) from operations                     279,700,000 (906,200,000) 113,700,000
Interest income                     1,300,000 1,300,000 2,300,000
Interest expense                     (220,600,000) (281,100,000) (140,300,000)
Debt extinguishment loss     (4,400,000) (2,900,000) (6,000,000)   (3,200,000) (3,200,000)     (7,400,000) (9,200,000) (42,300,000)
Other (expense) income, net                     (4,900,000) 2,300,000 4,900,000
Income (loss) before income taxes                     48,100,000 (1,192,900,000) (61,700,000)
Provision (benefit) for income taxes                     30,800,000 (20,100,000) 11,900,000
Equity in earnings (losses) of subsidiaries                     0 0 0
Net income (loss) 28,200,000 [1] 11,300,000 [1] (16,800,000) [1] (5,400,000) [1] (1,113,900,000) [2] (11,000,000) [2]   (51,100,000) [2] 3,100,000 [2]   17,300,000 (1,172,800,000) (73,600,000)
Eliminations [Member]
                          
Revenues:                          
Product                     (486,900,000) (362,800,000) (284,500,000)
Service and other                     (51,500,000) (53,600,000) (58,000,000)
Revenues                     (538,400,000) (416,400,000) (342,500,000)
Costs of revenues:                          
Product                     (486,900,000) (362,800,000) (284,500,000)
Amortization of intangible assets                     0 0 0
Impairment of intangible assets                     0 0  
Service and other                     (51,500,000) (53,600,000) (58,000,000)
Gross Profit                     0 0 0
Operating expenses:                          
Research and development                     0 0 0
Selling and marketing                     0 0 0
General and administrative                     0 0 0
Amortization of intangible assets                     0 0 0
Impairment of intangible assets                     0    
Contingent consideration – compensation expense                       0 0
Contingent consideration – fair value adjustments                       0 0
Impairment of goodwill                       0 0
Gain on sale of intellectual property                       0 0
Acquired in-process research and development                         0
Restructuring and divestiture charges                     0 0 0
Operating expenses                     0 0 0
Income (loss) from operations                     0 0 0
Interest income                     (3,700,000) 0 (600,000)
Interest expense                     3,700,000 0 0
Debt extinguishment loss                     0 0 0
Other (expense) income, net                     (10,700,000) 0 600,000
Income (loss) before income taxes                     (10,700,000) 0 0
Provision (benefit) for income taxes                     0 0 0
Equity in earnings (losses) of subsidiaries                     168,500,000 1,127,000,000 (34,700,000)
Net income (loss)                     157,800,000 1,127,000,000 (34,700,000)
Parent/Issuer [Member]
                          
Revenues:                          
Product                     480,100,000 416,900,000 421,000,000
Service and other                     354,000,000 326,700,000 307,100,000
Revenues                     834,100,000 743,600,000 728,100,000
Costs of revenues:                          
Product                     246,300,000 212,900,000 211,700,000
Amortization of intangible assets                     5,600,000 5,400,000 5,200,000
Impairment of intangible assets                     0 0  
Service and other                     161,200,000 157,400,000 155,600,000
Gross Profit                     421,000,000 367,900,000 355,600,000
Operating expenses:                          
Research and development                     30,700,000 29,800,000 28,100,000
Selling and marketing                     74,500,000 78,000,000 67,900,000
General and administrative                     61,300,000 68,900,000 52,600,000
Amortization of intangible assets                     3,100,000 3,000,000 2,700,000
Impairment of intangible assets                     0    
Contingent consideration – compensation expense                       80,000,000 81,000,000
Contingent consideration – fair value adjustments                       11,300,000 38,500,000
Impairment of goodwill                       0 0
Gain on sale of intellectual property                       0 0
Acquired in-process research and development                         0
Restructuring and divestiture charges                     8,400,000 4,900,000 0
Operating expenses                     178,000,000 275,900,000 270,800,000
Income (loss) from operations                     243,000,000 92,000,000 84,800,000
Interest income                     400,000 600,000 2,000,000
Interest expense                     (220,600,000) (277,800,000) (137,200,000)
Debt extinguishment loss                     (7,400,000) (9,200,000) (42,300,000)
Other (expense) income, net                     172,900,000 193,300,000 3,100,000
Income (loss) before income taxes                     188,300,000 (1,100,000) (89,600,000)
Provision (benefit) for income taxes                     3,300,000 30,800,000 9,700,000
Equity in earnings (losses) of subsidiaries                     (167,700,000) (1,140,900,000) 25,700,000
Net income (loss)                     17,300,000 (1,172,800,000) (73,600,000)
Guarantor Subsidiaries [Member]
                          
Revenues:                          
Product                     1,612,400,000 1,569,600,000 1,089,500,000
Service and other                     82,100,000 71,700,000 63,300,000
Revenues                     1,694,500,000 1,641,300,000 1,152,800,000
Costs of revenues:                          
Product                     630,600,000 636,700,000 396,700,000
Amortization of intangible assets                     299,300,000 298,400,000 192,400,000
Impairment of intangible assets                     0 0  
Service and other                     62,000,000 59,900,000 61,300,000
Gross Profit                     702,600,000 646,300,000 502,400,000
Operating expenses:                          
Research and development                     164,100,000 157,800,000 91,200,000
Selling and marketing                     169,700,000 176,000,000 170,400,000
General and administrative                     155,900,000 124,000,000 136,200,000
Amortization of intangible assets                     104,700,000 104,800,000 64,300,000
Impairment of intangible assets                     5,100,000    
Contingent consideration – compensation expense                       0 0
Contingent consideration – fair value adjustments                       0 0
Impairment of goodwill                       1,117,400,000 5,800,000
Gain on sale of intellectual property                       (53,900,000) (12,400,000)
Acquired in-process research and development                         4,500,000
Restructuring and divestiture charges                     17,000,000 21,600,000 16,200,000
Operating expenses                     616,500,000 1,647,700,000 476,200,000
Income (loss) from operations                     86,100,000 (1,001,400,000) 26,200,000
Interest income                     3,600,000 300,000 200,000
Interest expense                     (1,300,000) (1,300,000) (1,200,000)
Debt extinguishment loss                     0 0 0
Other (expense) income, net                     (167,400,000) (184,600,000) 700,000
Income (loss) before income taxes                     (79,000,000) (1,187,000,000) 25,900,000
Provision (benefit) for income taxes                     24,100,000 (59,200,000) (3,100,000)
Equity in earnings (losses) of subsidiaries                     (800,000) 13,900,000 8,400,000
Net income (loss)                     (103,900,000) (1,113,900,000) 37,400,000
Non-Guarantor Subsidiaries [Member]
                          
Revenues:                          
Product                     489,300,000 477,200,000 431,700,000
Service and other                     51,200,000 46,600,000 32,500,000
Revenues                     540,500,000 523,800,000 464,200,000
Costs of revenues:                          
Product                     341,300,000 331,400,000 292,900,000
Amortization of intangible assets                     9,700,000 4,100,000 4,300,000
Impairment of intangible assets                     26,600,000 1,700,000  
Service and other                     41,000,000 39,400,000 30,600,000
Gross Profit                     121,900,000 147,200,000 136,400,000
Operating expenses:                          
Research and development                     8,400,000 10,000,000 11,700,000
Selling and marketing                     87,500,000 88,100,000 84,000,000
General and administrative                     42,600,000 34,800,000 31,700,000
Amortization of intangible assets                     6,000,000 4,800,000 5,000,000
Impairment of intangible assets                     500,000    
Contingent consideration – compensation expense                       0 0
Contingent consideration – fair value adjustments                       0 0
Impairment of goodwill                       0 0
Gain on sale of intellectual property                       0 0
Acquired in-process research and development                         0
Restructuring and divestiture charges                     26,300,000 6,300,000 1,300,000
Operating expenses                     171,300,000 144,000,000 133,700,000
Income (loss) from operations                     (49,400,000) 3,200,000 2,700,000
Interest income                     1,000,000 400,000 700,000
Interest expense                     (2,400,000) (2,000,000) (1,900,000)
Debt extinguishment loss                     0 0 0
Other (expense) income, net                     300,000 (6,400,000) 500,000
Income (loss) before income taxes                     (50,500,000) (4,800,000) 2,000,000
Provision (benefit) for income taxes                     3,400,000 8,300,000 5,300,000
Equity in earnings (losses) of subsidiaries                     0 0 600,000
Net income (loss)                     $ (53,900,000) $ (13,100,000) $ (2,700,000)
[1] Net loss in the first quarter of fiscal 2014 included restructuring charges of $18.4 million and debt extinguishment loss of $2.9 million. Net loss in the second quarter of fiscal 2014 included an impairment charge related to the MRI breast coils product line of $28.6 million, restructuring charges of $11.6 million and a debt extinguishment loss of $4.4 million. Net income in the third quarter of fiscal 2014 included restructuring charges of $6.7 million. Net income in the fourth quarter of fiscal 2014 included restructuring and divestiture charges of $15.1 million and a $5.1 million IPR&D charge.
[2] Net income in the first quarter of fiscal 2013 included a gain on the sale of intellectual property of $53.9 million. Net loss in the second quarter of fiscal 2013 included restructuring charges of $12.5 million and a debt extinguishment loss of $3.2 million. Net loss in the third quarter of fiscal 2013 included restructuring charges of $6.7 million. Net loss in the fourth quarter of fiscal 2013 included a goodwill impairment charge of $1.1 billion, restructuring charges of $9.7 million and a debt extinguishment loss of $6.0 million.